A study looking at personalised treatment for early HER2 positive breast cancer (HER2-RADiCAL)
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This trial is looking at a drug called abemaciclib for women whose hormone therapy might not work so well.
This trial is looking at the need to treat the lymph glands in the armpit after having chemotherapy followed by surgery for breast cancer.
This study is for people with early breast cancer who are going to have a cancer drug treatment before surgery.
This study is to see if women who only have a very small risk of their breast cancer returning need to have radiotherapy after surgery.
This study is for people recently diagnosed with certain cancers who are waiting to have treatment.
This study is looking at biomarkers in tissue and blood samples of people with Hodgkin lymphoma to help tell how well the treatment is working.
This trial is looking at 2 tests called CEP17 and TOP2A to help doctors decide the best type of chemotherapy to give before surgery for invasive breast cancer.
This trial is looking at testing tissue samples to try and find if you might benefit from having chemotherapy to treat your breast cancer.
This trial compared 1 week of radiotherapy with 3 weeks of radiotherapy after surgery for breast cancer.